Personalized Vaccine Generated by Autologous Dendritic Cells Pulsed With Autologous Whole Tumor Cell Lysate Treat Advanced Solid Tumor Patients With High Tumor Mutation Burden

Summary

The study is to investigate the safety and efficacy of dendritic cells vaccines pulsed with autologous whole tumor cell lysate for treating advanced solid tumor patients with high tumor mutation burden.

Timeline

Start

2018-09-11

Primary completion

2021-12-30

Completion

2022-12-30

Outcome

Outcome not reported

Stopped (Enrollment): “No participants enrolled”

Drugs

Indications